Denmark allows unapproved pill for at-risk Covid-19 patients in line with EMA advice
![Photo: MSD / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13332424.ece/ALTERNATES/schema-16_9/doc7hs0lorhhnmsy1yqi80.jpg)
The Danish Health Authority is now allowing Danish doctors to use MSD's tablet treatment, Lagevrio (molnupiravir), to treat Covid-19 patients, despite the drug having yet to be formally approved by the European Medicines Agency (EMA), the Danish authority reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
EMA allows emergency use of MSD's Covid-19 capsule treatment
For subscribers
EMA to investigate Covid-19 treatment
For subscribers
EMA: Omicron cases appear "mostly mild"
For subscribers